Reaction
Glomerulonephritis Minimal Lesion reporting signals
As of the last recalculation, Glomerulonephritis Minimal Lesion appears in 716 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is OSELTAMIVIR (PRR 40.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Oseltamivir | 11 | 40.8 | 40.8 |
| Busulfan | 18 | 34.1 | 34.1 |
| Diclofenac | 75 | 28.2 | 28.2 |
| Rifampin | 13 | 26.3 | 26.4 |
| Rifampicin | 9 | 26.2 | 26.2 |
| Isoniazid | 14 | 25.6 | 25.6 |
| Pyrazinamide | 7 | 21.9 | 21.9 |
| Diclofenac Potassium, Film Coated | 4 | 13.9 | 13.9 |
| Diclofenac Potassium Tablets | 4 | 13.9 | 13.9 |
| Oseltamivir Phosphate | 11 | 13.3 | 13.3 |
| Diclofenac Potassium | 4 | 10.8 | 10.8 |
| Ipilimumab | 15 | 10.3 | 10.3 |
| Velpatasvir And Sofosbuvir | 3 | 6.8 | 6.8 |